Welcome to the Special Pathogens Excellence in Clinical Treatment, Readiness, and Education Program (SPECTRE) within the Division of Infectious Diseases at UTMB. The primary objectives of SPECTRE are to support preparedness of the UTMB Biocontainment
Care Unit (BCU) to care for patients with special pathogens, develop education and training regarding special pathogens care and research, to network with other health care and public health entities to assure a coordinated response, and to support
infrastructure for clinical research for special pathogens. Our team includes experts in their fields from the School of Medicine, Department of Global Health & Emerging Disease, Department of Biosafety, Environmental Health & Safety, and
Division of Infection Control & Healthcare Epidemiology.
SPECTRE team members collaborate with the National Emerging Special Pathogens Training and Education Center (NETEC) and Regional Emerging Special Pathogens Treatment Centers (RESPTCs) to develop new educational materials and training programs, share information
regarding care of special pathogens patients, develop infrastructure for research, and set the standard for preparedness efforts in the U.S.
SPECTRE activities fall into 4 overarching categories:
- Maintaining the BCU
- UTMB is home to a specialized patient care unit equipped to provide the highest standard of care to patients infected with highly dangerous pathogens
- UTMB is prepared to accept at least 2 special pathogens patients within 8 hours’ notice
- Training and education
- Internal training for UTMB employees, including not only the BCU health care team but providers throughout the institution who may encounter special pathogens patients
- External training and education for other healthcare systems, associations, and the community
- Within our 5-state Health & Human Services (HHS) Region VI: Texas, Arkansas, Louisiana, Oklahoma, New Mexico
- Nationally with the National Special Pathogens System (NSPS)
- Research Infrastructure
- Maintain capacity to quickly implement clinical trial protocols in an outbreak response
- Established and support the Biorepository for Severe and Emerging Infections (BSEI)
- Conduct clinical, human factor, and environmental biosafety research within the BCU
We look forward to continuing to work with our internal and external partners in building and enhancing special pathogens preparedness efforts for our region.
Susan McLellan, MD, MPH
Medical Director, Biocontainment Care Unit